Intraoperative diagnosis of central nervous system (CNS) neoplasms is limited by marked artifacts due to ice crystals during freezing and the difficulty of observing nuclear details of the tumor cells \[[@b1-jptm-2018-11-10]\]. Since the first study of intraoperative cytological smears of CNS lesions in 1930 by Eisenhardt and Cushing \[[@b2-jptm-2018-11-10]\], the use of smear cytology has increased in the diagnosis of CNS neoplasms. Recently, diagnosing CNS neoplasms has shown a rapid transition to molecular incorporation for layered diagnoses. However, cytology continues to provide important clues in frozen diagnoses of CNS neoplasms \[[@b3-jptm-2018-11-10]\]. Few studies exist relating to cytomorphologic significance, especially on frozen diagnoses, and inadequate experience and resultant poor interpretations hinder conclusive diagnoses.

Herein, we evaluate the diagnostic accuracy of intraoperative combined cytology and frozen sections in the diagnosis of CNS neoplasms.

MATERIALS AND METHODS
=====================

We retrieved 454 cases that underwent both intraoperative frozen cytologic smears and frozen section slides of brain and cord from the archives of the Department of Pathology at a tertiary referral hospital from 2006 to 2015. In cases where only small specimens were submitted, only frozen cytology was examined. The frozen cytology was prepared by squash or touch smears, which were immediately immersed in 95% ethanol for two minutes and stained with hematoxylin and eosin (H&E). The remaining specimens were frozen sectioned; the tissue was processed in a cryostat at -15°C. Thin sections (5-μm thickness) were made and then stained using H&E \[[@b4-jptm-2018-11-10]\]. The frozen diagnoses were compared to permanent diagnoses. Disease entities were classified according to the 2007 World Health Organization (WHO) classification of CNS tumors with the combined application of new concepts from the 2016 revised edition, e.g., solitary fibrous tumors/hemangiopericytoma \[[@b5-jptm-2018-11-10],[@b6-jptm-2018-11-10]\]. To determine discordance, we categorized cases as complete concordance, partial concordance, discordance, and deferred cases including inadequate samples. Cases were considered complete concordance when specified frozen entities were the same as final ones, and as partial concordance when entities were not conclusive, but suggestive upon frozen diagnosis. Cases were considered deferred when, for example, glioblastoma was reported as suspicious for glioblastoma. We arbitrarily defined major and minor entities when the incidence was more than 10% or less than 10%, respectively. Comparison between diagnostic accuracy was assessed using chisquare tests in SPSS ver. 17 (SPSS Inc., Chicago, IL, USA), and p \< .05 was considered significant. All procedures were in accordance with the Helsinki Declaration of 1964 and later versions. This study is approved by Gil Medical Center's Institutional Review Board (GBIRB2016-323), and informed consent from patients was waived.

RESULTS
=======

Diseases diagnosed through smear cytological examination
--------------------------------------------------------

The most commonly encountered diseases were meningiomas, followed by (in order of decreasing frequency) pituitary adenomas, low- and high-grade astrocytic gliomas, and metastatic tumors. The cytologic features are shown in [Fig. 1](#f1-jptm-2018-11-10){ref-type="fig"}. The results are shown in [Table 1](#t1-jptm-2018-11-10){ref-type="table"}.

Concordance rate by disease entities
------------------------------------

The accuracy of cytology was 87.2% (396/454), and reached 98.8% (396/401) after excluding deferred cases (n = 53). Five cases were categorized as discordant ([Table 2](#t2-jptm-2018-11-10){ref-type="table"}, [Fig. 2](#f2-jptm-2018-11-10){ref-type="fig"}). Minor disease entities showed low complete concordance (less than 50%), compared with major disease entities showing high concordance (range, 69% to 95.5%). When excluding metastatic brain tumors, disease entities comprising more than 10% of the total showed statistically significant diagnostic accuracy by frozen cytology, compared to less common tumors (meningioma including atypical ones, pituitary adenoma, high-grade glioma and schwannoma) (p \< .001).

Deferred cases
--------------

Tentative diagnoses in the present study were 6.8% (n = 31) and were categorized as deferred diagnoses, except in the case of inadequate samples. These results are shown in [Table 3](#t3-jptm-2018-11-10){ref-type="table"}. The rates of deferred cases between major disease entities (i.e., more than 10% of incidence) and non-major disease entities were significantly different (p \< .001).

DISCUSSION
==========

The present study retrospectively assessed the use of both cytology and frozen sections, so direct comparison of the frozen cytology and frozen sections is limited. The use of intraoperative frozen sections of CNS neoplasms has long been an important diagnostic tool, but agreement varies among histopathological entities and shows low sensitivity in diagnosing low-grade tumors and edematous lesions, compared to intraoperative frozen cytology. Various limitations in frozen diagnoses of CNS neoplasms exist in both frozen cytologic smears and frozen sections. Due to their soft, friable, and watery nature, frozen sections frequently have marked freezing artifacts and ice crystals, resulting in obscured nuclear details. These limitations may be resolved by frozen cytology, except for CNS lesions with a firm consistency such as schwannomas, metastatic carcinomas, or non-neoplastic inflammatory lesions. In the latter lesions, only frozen sections can maintain architectural morphology and subsequently yield high diagnostic accuracy. Here, we retrospectively assessed diagnostic utility using both frozen cytology and frozen sections; discrepancies between frozen diagnosis and final diagnosis may be ascribed to sampling error and incorrect evaluation of histologic typing or grading \[[@b7-jptm-2018-11-10]\]. Except for grading, previous studies showed the most sensitive yield was achieved in tumors including astrocytoma, meningioma, oligodendroglioma, metastatic tumor, glioblastoma, and ependymoma in descending order \[[@b3-jptm-2018-11-10],[@b8-jptm-2018-11-10]\]. Glial tumors show heterogeneous distribution \[[@b9-jptm-2018-11-10]\]; high grade, i.e., grades III and IV astrocytic tumors may be diagnosed as low-grade tumors in frozen diagnosis \[[@b10-jptm-2018-11-10]\]. These errors can be avoided by taking samples from multiple portions of the tumors \[[@b11-jptm-2018-11-10]\]. In frozen cytology and sections of glial lesions, discrimination between normal brain reactive gliosis versus low-grade gliomas (WHO grades I and II) is difficult; evaluation of true cellularity is limited in both frozen cytology and frozen sections. Increased gliosis is insufficient to diagnose glioma. Features showing unevenly distributed astrocytes with mild nuclear irregularities, no discernible cytoplasm, high nuclear to cytoplasmic ratios, and hyperchromatic chromatin favor lowgrade glioma. Low cellular smears composed of spindle cells, especially the peripheral areas of high-grade gliomas, are difficult to interpret. Radiation injury may mimic glioblastoma by cytological findings such as bizarre nuclear features \[[@b12-jptm-2018-11-10]\]. Necrosis and vascular endothelial proliferation are reliable cytologic findings of high-grade glioma \[[@b10-jptm-2018-11-10],[@b13-jptm-2018-11-10],[@b14-jptm-2018-11-10]\]. Because they share clinicoradiologic findings, glioblastoma should be distinguished from metastasis and lymphoma. Glioblastoma is characterized by highly malignant cells and endovascular proliferation, i.e., a bulbous collection of overlapped and haphazardly oriented nuclei attached to vessels on frozen cytology \[[@b15-jptm-2018-11-10]\]. On the other hand, lymphoma cytology lacks endovascular proliferation, shows no tumor cells within the walls of blood vessels, exhibits a spread of atypical, round nuclei with vesicular, open chromatin and distinct nucleoli, and displays abundant lymphoglandular bodies with tingible body macrophages in the background. Pleomorphic xanthoastrocytoma belongs to astrocytic tumors showing marked nuclear pleomorphism with no mitotic activity in frozen cytology \[[@b16-jptm-2018-11-10]\].

Among CNS neoplasms showing spindle cell morphology, frozen cytology samples of meningothelial neoplasms are notorious for having diverse cytologic findings. Most conventional, lowgrade meningiomas show nuclear inclusion or vesicular nuclear clearing and thick collagenous cytoplasm as well as syncytial whorls \[[@b17-jptm-2018-11-10]\]. Compared to low-grade meningiomas, high-grade meningiomas such as rhabdoid or papillary types (WHO grade III) may share cytological findings of ependymoma because meningiomas of rhabdoid or papillary types show few meningothelial whorls and predominant perivascular rosette-like arrangements that were misdiagnosed as ependymoma \[[@b18-jptm-2018-11-10]\]. Nuclear inclusions on cytologic smears may be shared by these two disease entities \[[@b15-jptm-2018-11-10],[@b18-jptm-2018-11-10]\]. Eosinophilic hyalinized cytoplasm and hyaline globules of rhabdoid meningioma should be distinguished from atypical teratoid/rhabdoid tumors, germinoma, or embryonal carcinomas \[[@b19-jptm-2018-11-10]\]. Even anaplastic meningioma shows pleomorphic cells, mimicking carcinoma or sarcoma. Schwannomas lack whorls and have elongated, wavy cytoplasm \[[@b15-jptm-2018-11-10],[@b20-jptm-2018-11-10]\]. Distinguishing meningioma and schwannoma is not difficult in most cases. However, uncommon locations such as intracerebral or sellar schwannoma require careful intraoperative diagnoses \[[@b21-jptm-2018-11-10]\].

Round cell lesions such as oligodendroglioma containing abundant thin capillary structures may easily exclude astrocytic lesions due to a perinuclear halo artifact that is typically seen in permanent formalin-fixed processing of oligodendrogliomas \[[@b14-jptm-2018-11-10],[@b22-jptm-2018-11-10]\]. Cytological smears of oligodendroglioma-mimicking round cell tumors such as central neurocytoma, hemangioblastoma, metastatic clear cell renal cell carcinoma, and dysembryoplastic neuroepithelial tumor should be differentiated from oligodendroglioma and small cell glioblastoma \[[@b23-jptm-2018-11-10],[@b24-jptm-2018-11-10]\]. Central neurocytoma, an oligodendroglioma-mimicker, is a well-differentiated tumor showing features of neuronal differentiation that may mimic the frozen histology of oligodendroglioma, clear cell ependymoma, or even necrotic glioblastoma due to eosinophilic acellular fibrillary areas masquerading as necrotic portions under frozen histologic sections, despite the small round cells having fine, granular nuclear chromatin and cytoplasm \[[@b20-jptm-2018-11-10],[@b25-jptm-2018-11-10]\]. When pathologists observe cytological findings such as arborizing thin-walled vasculature, calcification, or mucoid foci, these shared features should be distinguished from clear cell ependymoma, central neurocytoma, or oligodendroglioma. Nuclear features that include a salt-pepper appearance are features of neurocytoma, but cellular areas with alternating acellular fibrillary neuropil-rich areas may mimic or be easily misinterpreted as ependymal rosettes \[[@b24-jptm-2018-11-10]\]. Nuclear details of ependymomas are distinguished from those of neurocytomas by the presence of nuclear grooves and nuclear inclusions \[[@b25-jptm-2018-11-10]\]. On observing nuclear features, round to oval nuclei with stippled chromatin, as well as nuclear grooves and intracytoplasmic lumina, are seen in ependymomas \[[@b18-jptm-2018-11-10]\]. Clear cell ependymoma, one of the oligodendroglioma-mimickers, may pose a significant diagnostic challenge because cytological findings of a few cells with a clear cytoplasm and eccentric nucleus are unconventional for ependymoma \[[@b20-jptm-2018-11-10]\]; conventional type ependymomas show a distinct cytomorphology, but less-epithelial variants of ependymomas, such as tanycytic variants, may resemble astrocytic tumors even in cytological smears \[[@b26-jptm-2018-11-10]\]. Ependymomas having acellular perivascular fibrillary pseudorosettes are composed of round-shaped, monotonous, cohesive tumor cells \[[@b25-jptm-2018-11-10]\]. However, cytological findings such as loosely arranged monotonous round-shaped tumor cells with small nuclei and stippled chromatin have provided diagnostic distinguishing points in cases with acellular fibrillary areas scattered in the cytology smears \[[@b1-jptm-2018-11-10]\]. The WHO classification of CNS neoplasms classifies ependymomas into three grades, considering parameters of cellularity, pleomorphism, mitosis, necrosis, and microvascular proliferation \[[@b6-jptm-2018-11-10]\]. Cellular pleomorphism and microvascular proliferation were the most reliable indicators of WHO grade III ependymomas compared to mitosis or necrosis patterns \[[@b27-jptm-2018-11-10]\]. Intraoperative cytological characteristics of ependymomas are well described, but cytologic characteristics by grading are rarely documented.

Intraoperative frozen sections provide an important tool, but agreement varies among histopathological entities and is lower in low-grade tumors than in high-grade tumors, compared to intraoperative cytology \[[@b28-jptm-2018-11-10]\]. For example, frozen diagnosis of meningiomas is not different from intraoperative cytology. Because the present study retrospectively assessed the use of both cytology and frozen sections, direct comparison of the two is limited. The cytologic characteristics described here with frozen sections revealed that diagnostic accuracy of intraoperative frozen diagnosis was 87.2% (396/454), and the accuracy was elevated up to 98.8% after excluding deferred cases. Two out of five discordant cases were ascribed to sampling error taken from nonrepresentative tissue portions. The remaining three cases were misinterpreted as reactive gliosis or low-grade tumors in bloody backgrounds. Bloody backgrounds may contribute to false negative diagnoses, so clinical confirmation is always desirable in unusual smears. With respect to correct grading of glial tumors, concordance of glial tumors was low. Distinguishing between reactive gliosis and lowgrade gliomas is limited and difficult, by both frozen cytology and frozen section \[[@b3-jptm-2018-11-10]\]. Non-neoplastic CNS lesions mimicking glial tumors include demyelinating diseases and tissue-destructive lesions such as infarctions, abscesses, radio-necrosis, and areas with resolving hemorrhage \[[@b22-jptm-2018-11-10],[@b29-jptm-2018-11-10]\].

These cytomorphologic features in conjunction with the clinical history and radiologic findings provided an accurate diagnosis in 87.2% of the cases in the present study, similar to previous studies reporting a diagnostic accuracy varying from 86% to 97.3% \[[@b1-jptm-2018-11-10],[@b30-jptm-2018-11-10]\]. Relatively high concordance rates of major disease entities in the present study are related with frequent exposure and experience with those CNS neoplasms. This diagnostic accuracy can be improved through knowledge of clinical and neuroimaging correlation as well as experienced pathologists.

Given the clinical significance of intraoperative tentative diagnoses of CNS lesions, it is important to examine cytological smears and frozen sections combined with clinicoradiologic findings to increase diagnostic accuracy. Intraoperative frozen diagnoses using combined cytology and frozen sections encompass limitations in layered diagnosis according to revised upcoming WHO classifications and inevitable deferral of grading, and awareness of these pitfalls is important for neuropathologists and neurosurgeons. Despite the limitations of retrospective studies, this study describes the 10-year retrospective experience of prompt and accurate intraoperative frozen section diagnoses in CNS lesions with the combined use of smear cytology and highlights its diagnostic value as a reliable method.
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![(A, B) Ependymoma. Spindle-shaped tumor cells around thin capillaries. Note fibrillary cytoplasm and occasional nuclear inclusion. (C, D) Glioblastoma. Clusters show ovoid to slightly elongated hyperchromatic nuclei with occasional mitosis. Note necrosis in the extracellular area. (E, F) Fibrous meningioma. Ovoid to spindle cells have round to elongated nuclei with fine chromatin. Note nuclear pseudoinclusion and meningothelial whorls. (G, H) Rhabdoid and papillary meningioma. Papillae have thick collagenous cytoplasm rather than fibrillary features that are commonly found in ependymoma.](jptm-2018-11-10f1){#f1-jptm-2018-11-10}

![Discordant cases. (A, B) Spindle cells with occasional atypical cells are mixed with karyorrhectic debris (A), and glioblastoma is diagnosed in the permanent section (B). (C, D) A tiny focus of round cells shows eosinophilic fibrillary cytoplasm in a bloody background (C), and diffuse astrocytoma is diagnosed in the permanent section (D). (E) Only one cluster of squamoid epithelium is seen in frozen smears. (F) Immature teratoma with neuroepithelium is finally diagnosed in permanent section.](jptm-2018-11-10f2){#f2-jptm-2018-11-10}

###### 

Diagnostic comparison between frozen cytological diagnoses and permanent histologic diagnoses

  Disease entities                                 Completely concordant cases   Partially concordant cases   Sum of concordant cases   Discordant cases   Deferred cases including inadequate samples
  ------------------------------------------------ ----------------------------- ---------------------------- ------------------------- ------------------ ---------------------------------------------
  Meningioma (n = 98)                              91 (92.9)                     6 (6.1)                      97 (99.0)                 1 (1)              0
  Pituitary adenoma (n = 89)                       85 (95.5)                     1 (1.1)                      86 (96.6)                 0                  3 (3.4)
  Glial tumor                                                                                                                                              
   Astrocytic tumor, high grade (n = 58)           40 (69.0)                     7 (12.1)                     47 (81.1)                 2 (3.4)            9 (15.5)
   Astrocytic tumor, low grade (n = 13)            4 (30.8)                      6 (46.2)                     10 (76.9)                 1 (7.7)            2 (15.4)
   Ependymoma (n = 10)                             3 (30.0)                      1 (10.0)                     4 (40.0)                  0                  6 (60.0)
   Oligodendroglioma (n = 3)                       2 (66.7)                      1 (33.3)                     3 (100)                   0                  0
   Anaplastic oligodendroglioma (n = 3)            3 (100)                       0                            3 (100)                   0                  0
  Neurogenic tumor                                                                                                                                         
   Schwannoma (n = 47)                             38 (80.9)                     7 (14.9)                     45 (95.7)                 0                  2 (4.3)
   Neurofibroma (n = 2)                            0                             2 (100)                      2 (100)                   0                  0
  Dysembryoplastic neuroepithelial tumor (n = 2)   1 (50)                        1 (50)                       2 (100)                   0                  0
  Germ cell tumor (n = 3)                          1 (33.3)                      0                            1 (33.3)                  1 (33.3)           1 (33.3)
  Malignant SFT/HP (n = 3)                         1 (33.3)                      0                            1 (33.3)                  0                  2 (66.7)
  Hematologic malignancy (n = 9)                   3 (33.3)                      5 (55.6)                     8 (88.9)                  0                  1 (11.1)
  Metastatic tumor (n = 52)                        46 (88.5)                     5 (9.6)                      51 (98.1)                 0                  1 (1.9)
  Other malignant tumors (n = 6)                   1 (16.7)                      2 (33.3)                     3 (50)                    0                  3 (50)
  Other benign tumors (n = 20)                     8 (40.0)                      2 (10.0)                     10 (50)                   0                  10 (50.0)
  Non-neoplastic lesions (n = 36)                  19 (52.8)                     4 (11.1)                     23 (63.9)                 0                  13 (36.1)
  Total cases (n = 454)                            346 (76.2)                    50 (11.0)                    396 (87.2)                5 (1.1)            53 (11.7)

Values are presented as number (%).

SFT/HP, solitary fibrous tumor/hemangiopericytoma.

###### 

Comparison between frozen and permanent diagnoses and analysis of reason for diagnostic error of discordant cases

  Case No.   Frozen cytology and section diagnosis                                           Permanent diagnosis                 Reason for error
  ---------- ------------------------------------------------------------------------------- ----------------------------------- --------------------------
  1          Atypical glial cell proliferation with necrotic debris, favor reactive change   Diffuse astrocytoma                 Misinterpretation
  2          Consistent with benign glial tumor                                              Glioblastoma                        Misinterpretation
  3          Histiocytic lesion                                                              Glioblastoma                        Nonrepresentative sample
  4          Ependymoma                                                                      Papillary and rhabdoid meningioma   Misinterpretation
  5          Squamous epithelium, suggestive of craniopharyngioma                            Immature teratoma                   Nonrepresentative sample

###### 

Deferred cases excluding inadequate specimens in the frozen diagnoses

  Disease entities                                      No.
  ----------------------------------------------------- -----
  Pituitary adenoma                                     3
  Astrocytic tumor, low grade                           2
   Gliomatosis cerebri                                  1
   Pilomyxoid astrocytoma                               1
  Astrocytic tumor, high grade                          8
   Glioblastoma                                         5
   Anaplastic astrocytoma                               3
  Ependymoma                                            6
   Ependymoma                                           3
   Cellular ependymoma                                  1
   Myxopapillary ependymoma                             2
  Schwannoma                                            1
  Germ cell tumor                                       1
   Mature teratoma                                      1
  Malignant solitary fibrous tumor/hemangiopericytoma   2
  Hematologic malignancy                                1
   Plasmacytoma                                         1
  Metastatic tumor                                      1
   Metastatic adenocarcinoma                            1
  Other malignant tumor                                 2
   Hemangioblastoma                                     2
  Other benign tumors                                   4
   Vascular malformation                                1
   Hemangioma                                           2
   Rathke's cleft cyst                                  1
  Non-neoplastic lesions                                1
  No diagnostic abnormality                             1
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